drugset / Trial / NCT00547469

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

NCT00547469 ↗

Phase 2/3 Unknown 360 enrolled Dynogen Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.

Timeline

Start
2007-10
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject DDP733 Unknown — —